Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody

BACKGROUND: Many commercial assays, of different designs, detecting SARS-CoV-2-specific antibodies exist but with little experience with them. OBJECTIVES: The aim of this study was to compare the performance of assays detecting IgG or total antibodies to N or S antigens, validated for routine use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Trabaud, Mary-Anne, Icard, Vinca, Milon, Marie-Paule, Bal, Antonin, Lina, Bruno, Escuret, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476603/
https://www.ncbi.nlm.nih.gov/pubmed/32942137
http://dx.doi.org/10.1016/j.jcv.2020.104613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476603/
https://www.ncbi.nlm.nih.gov/pubmed/32942137
http://dx.doi.org/10.1016/j.jcv.2020.104613

Ejemplares similares